SCHEMBL79493

SCHEMBL79493

CCCCCCCCCCC(CCCCCCCC)COC(=O)C(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 2/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
TSHR P16473 2/20 0.45
CYP3A4 P08684 2/20 0.45
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LMNA P02545 2/20 0.44
PRKCA P17252 1/20 0.43
ZDHHC7 Q9NXF8 1/20 0.43
CA2 P00918 2/20 0.42
GPR84 Q9NQS5 4/20 0.40
USP2 O75604 1/20 0.40
FFAR1 O14842 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 2/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18595283 1.00 PRSS1 (0.48) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL18334305 1.00 PRSS1 (0.48) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL26312888 0.98 TSHR (0.47) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL18558928 0.93 PRSS1 (0.56) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL16736958 0.88 CYP4F2 (0.50) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL3324957 0.88 CYP4F2 (0.50) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL3847081 0.86 CYP3A4 (0.62) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL26711159 0.83 ACACB (0.51) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL26711151 0.83 ACACB (0.51) PRSS1PRSS2PRSS3TSHRCYP3A4
SCHEMBL20623084 0.82 PRKCA (0.39) PRSS1PRSS2PRSS3TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1045 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616647-B2 Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles L'OREAL (FR) 2026-05-05 US claimed
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US claimed
EP-4704803-A1 COMPOSITIONS AND METHODS COMPRISING A LOTUS FLOWER EXTRACT BLEND AND/OR CONSTITUENTS THEREOF FOR TREATING SKIN Coty Inc. (US) 2026-03-11 EP claimed
EP-4688908-A2 CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF Momentive Performance Materials Inc. (US) 2026-02-11 EP claimed
EP-4688909-A1 POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONO-CARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS Momentive Performance Materials Inc. (US) 2026-02-11 EP claimed
US-20260034046-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL L'OREAL (FR) 2026-02-05 US claimed
US-20260000602-A1 ANHYDROUS HAIR TREATMENT COMPOSITION L'OREAL (FR) 2026-01-01 US claimed
EP-3976121-B1 ADHESIVE COMPOSITIONS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-10-15 EP claimed
US-20250281376-A1 Hair Care Composition CORET JOEL MARCEL (US) 2025-09-11 US claimed
US-12370135-B2 Anhydrous composition for caring for and/or making up keratin materials L'OREAL (FR) 2025-07-29 US claimed
US-20220105018-A1 ANTIMICROBIAL COMPOSITION SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-04-07 US claimed
US-20220089475-A1 CONDUCTIVE PASTE FOR SOLAR CELL ELECTRODE AND SOLAR CELL MANUFACTURED USING SAME LS MNM INC. (KR) 2022-03-24 US claimed
WO-2022041217-A1 A COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2022-03-03 WO claimed
US-20220023161-A1 SUNSCREEN FORMULATION FALLIEN COSMECEUTICALS, LTD. 2022-01-27 US claimed
US-8137449-B2 Inkjet ink RISO KAGAKU CORPORATION (JP) 2012-03-20 US claimed
US-7799123-B2 Inkjet ink RISO KAGAKU CORPORATION (JP) 2010-09-21 US claimed
EP-1783183-B1 Inkjet ink RISO KAGAKU CORP (JP) 2010-04-28 EP claimed
US-20090198003-A1 Inkjet ink RISO KAGAKU CORPORATION (JP) 2009-08-06 US claimed
US-20070101901-A1 Solution of a pigment in a mixture of 30-70% non-polar solvent, and 20% or more of an ester solvent having an alpha value of 6-8 degrees, such as isooctyl palmitate, isooctyl isopalmitate or 2-octyldodecyl pivalate; produces prints that do not stick to a print printed by a plain paper or a laser copier RISO KAGAKU CORPORATION (JP) 2007-05-10 US claimed
EP-1783183-A1 Inkjet ink Riso Kagaku Corporation (JP) 2007-05-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260000602-A1 ANHYDROUS HAIR TREATMENT COMPOSITION TAS2R40, BRDT, APOB PRSS1 3978/4885PRSS2 3756/4885PRSS3 2733/4885
US-20260034046-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL KRT18, DSG1, PRKDC PRSS1 3816/4885PRSS2 3011/4885PRSS3 2237/4885
US-12370135-B2 Anhydrous composition for caring for and/or making up keratin materials KRT18, VIM, PLOD3 PRSS1 1489/4885PRSS2 2433/4885PRSS3 1615/4885
US-12616647-B2 Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles SMURF1, EBP, SPTLC3 PRSS1 2434/4885PRSS2 2231/4885PRSS3 820/4885
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN TRPV1, SPTLC3, FFAR3 PRSS1 2666/4885PRSS2 2905/4885PRSS3 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.